Hormonal profile in pubertal females with chronic renal failure: Before and under haemodialysis and after renal transplantation

1987 ◽  
Vol 115 (3) ◽  
pp. 289-296 ◽  
Author(s):  
Jorge R. Ferraris ◽  
Horacio M. Domene ◽  
Maria E. Escobar ◽  
Maria G. Caletti ◽  
Jose A. Ramirez ◽  
...  
Keyword(s):  
Renal Failure ◽  
Renal Transplantation ◽  
Chronic Renal Failure ◽  
Tanner Stage ◽  
Breast Development ◽  
Hormonal Profile ◽  
Serum Lh ◽  
Group A ◽  
Pubertal Stages ◽  
Group B

Abstract. The effects of chronic renal failure on the hypothalamic-pituitary-ovarian axis in 25 girls, aged 9.1 to 20.9 years (mean 13.8) were studied. Twelve patients on conservative treatment (group A) had serum creatinine values between 176.8 and 1502.8 μmol/l; 9 patients were on haemodialysis (group B); and 12 patients had received a renal transplant (group C). Tanner stage of breast development was delayed relative to chronological age in 5 out of 18 patients. Serum oestradiol was normal or low when related to pubertal stages in all groups. Serum LH was elevated in group A and B patients, but normal in group C patients. Serum FSH was elevated in 6 out of the 21 patients in group A plus B, and in 2 out of the 12 patients in group C. Serum PRL was elevated in 12/12, 6/8, and 4/11 patients in group A, B, and C respectively. After GnRH administration to 4 patients in group A, 3 showed delayed or absent gonadotropin response; all 4 patients studied in group C showed normal gonadotropin response. The data indicate a decreased E2 secretion, abnormal gonadotropin and PRL levels and a blunted gonadotropin response to GnRH in girls with chronic renal failure. These results seem to indicate an alteration of the hypothalamic-pituitary unit that can be reversed after successful renal transplantation.

scholarly journals Effects of Different Hemodialysis Treatments on Abnormal Mineral and Bone Metabolism in Patients with Chronic Renal Failure

2020 ◽  
Vol 4 (6) ◽  
Author(s):  
Qiang Li
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
Bone Metabolism ◽  
Type I ◽  
High Flux ◽  
Blood Calcium ◽  
Amino Terminal ◽  
Group A ◽  
The Difference ◽  
Group B

Objective: To investigate the effects of different hemodialysis treatments on abnormal mineral and bone metabolism in patients with chronic renal failure. Methods: A random number table was used to divide 80 patients with chronic renal failure admitted to our hospital from January 2018 to January 2019 into 2 groups, with 40 cases in each group. Group A was treated with low-flux hemodialysis, and group B was treated with high-flux hemodialysis. The related indicators of mineral and bone metabolism of the two groups were compared. Results: Before treatment, the blood calcium, blood phosphorus, intact parathyroid hormone (iPTH), type I procollagen amino terminal peptide (PINP), fibroblast growth factor 23 (FGF23), serum creatinine (Scr) indicators of the two groups were compared. The difference was not statistically significant(P>0.05); After treatment, the blood calcium levels of the two groups were higher than before treatment, the blood phosphorus, iPTH, PINP, FGF23, and Scr levels were lower than before treatment, and the blood calcium level of group B was higher than that of group A, while blood phosphorus, iPTH, PINP, FGF23, and Scr levels were lower than group A, the difference was statistically significant (P<0.05). Conclusion: Compared with low-flux hemodialysis, patients with chronic renal failure treated with high-flux hemodialysis have better results, which can correct abnormal bone metabolism and improve Scr levels.

scholarly journals Pattern of Lipid Profile in Chronic Renal Failure Patient with GFR < 60 ml/min/1.73 m2 on Conservative Treatment Versus Maintenance Haemodialysis

2016 ◽  
Vol 27 (2) ◽  
pp. 55-61
Author(s):  
Md Daharul Islam ◽  
Mohammad Rafiqul Islam ◽  
SM Tajdit Rahman ◽  
Khaleda Akhter ◽  
Adiba Tarannum ◽  
...  
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
Conservative Treatment ◽  
Lipid Profile ◽  
Chronic Renal Failure Patient ◽  
Renal Failure Patient ◽  
Maintenance Haemodialysis ◽  
Stage 4 ◽  
Group A ◽  
Group B

The incidence and prevalence of chronic kidney disease (CKD) are increasing worldwide and are associated with poor outcomes. It becomes apparent that the severity of CKD along with CVD severity in any population makes a devastated combination for both patients and healthcare system. Identification of CKD as a major risk factor for cardiovascular morbidity and mortality is attributed to dyslipidemia, and therefore an expectation of effective intervention to diminish premature cardiovascular mortality and progression of renal disease to increase longevity is imperative, thus this study may explore the lipid profile in chronic renal failure patient; on conservative treatment and maintenance haemodailysis treatment. A cross sectional comparative study was carried out to find out the Pattern of lipid profile in chronic renal failure patient with GFR < 60 ml/min on conservative treatment versus maintenance haemodialysis admitted in a selected hospital of Dhaka city. Total 128 study population were selected according to selection criteria among which 62 subjects were on maintenance dialysis (designated as group A) and 66 subjects were on conservative treatment of CKD (designated as group B). On average cholesterol, LDL and triglyceride level were more in group B than group A. On the other hand, HDL level was more in group A than group B and it was statistically insignificant. At the same time average LDL/HDL ratio was higher in group B than group A. But all these differences were statistically insignificant. Among the group A patients average triglyceride, total cholesterol and LDL level were higher in stage 4 CKD patients than stage 5 CKD patients. Average HDL level was higher in stage 5 CKD patients than stage 4 CKD patients. Among the group B patients average triglyceride and LDL level were higher in stage 4 CKD patients. But none of these two differences were statistically significant. On the other hand, average total cholesterol level was higher in stage 3 CKD patients and it was statistically significant(p<0.05). HDL level was higher in stage 5 patients. But this difference was not statistically significant. In group A LDL/HDL ratio was more in stage 4 CKD patients and it was statistically significant(p<0.05). Average LDL/HDL ratio was highest in stage 4 CKD patients in group B and it was statistically significant (p<0.05). Our study had showed that mean lipid profile is better in patients of CKD on dialysis than those on conservative treatment, but there is no statistical significance as sample size very small. A multicentric prospective study involving larger number of study population giving adequate statistical power is recommended for conclusive comment on the possible factors associated with dyslipidaemia in CKD patients.Bangladesh J Medicine Jul 2016; 27(2) : 55-61

THE INFLUENCE OF CHRONIC RENAL FAILURE ON SERUM AND URINARY THYROID HORMONE LEVELS

1978 ◽  
Vol 89 (1) ◽  
pp. 80-88 ◽  
Author(s):  
Klaus Kølendorf ◽  
Birger Broch Møller ◽  
Preben Rogowski
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
Statistical Significance ◽  
Thyroid Stimulating Hormone ◽  
Serum Free ◽  
Total Triiodothyronine ◽  
Total Thyroxine ◽  
Group A ◽  
Uptake Test ◽  
Group B

ABSTRACT The effects of various degrees of chronic renal failure on serum and urinary thyroid hormones were studied in 10 patients with a mean creatinine clearance (Cr.Cl.) of 23 ml/min (group A), in 11 patients with a Cr.Cl. of 5.7 ml/min (group B), and in 60 healthy euthyroid subjects with normal renal function. We found a significant decrease (P < 0.01) of serum total thyroxine (T4) (5.3 ±1.9 (sd) μg/100 ml in group A and 4.1 ± 1.5 in group B), serum total triiodothyronine (T3) (65.4 ± 17.4 ng/100 ml ~57.4 ± 13.9), serum free T4 (5.60 ± 1.74 arb.U ∼ 4.45 ± 1.61), and serum free T3 (69.51 ± 21.22 arb.U ∼ 62.09 ± 12.39). T3 uptake test and basal thyroid stimulating hormone (TSH) values were normal in both groups of renal patients. No statistical significance was found in T4 excretion in urine. Urinary T3 excretion was significantly reduced (P < 0.01) in group A (27 ± 44 ng/24 h), and undetectable in terminal renal failure. Urinary protein excretion was non-selective and low (median 0.2 g/24 h and 0.7 g/24 h, respectively). Conclusively we have found reduced levels of serum total and free T3, and in contradiction to most investigators substantially reduced levels of serum total and free T4. Urinary excretion of T4 and T3 reflects the low levels of free serum hormones and the tubular impairment.

A Case of Living-Donor Renal Transplantation for Chronic Renal Failure Caused by Secondary Amyloidosis

2011 ◽  
Vol 43 (6) ◽  
pp. 2418-2420 ◽  
Author(s):  
K. Sakai ◽  
M. Okamoto ◽  
K. Koshino ◽  
T. Suzuki ◽  
S. Nobori ◽  
...  
Keyword(s):  
Renal Failure ◽  
Renal Transplantation ◽  
Chronic Renal Failure ◽  
Living Donor ◽  
Secondary Amyloidosis

P1652IMPACT OF HEPATITIS C VIRUS AND DIRECT ACTING ANTIVIRALS ON JAPANESE RENAL ALLOGRAFT RECIPIENTS

2020 ◽  
Vol 35 (Supplement_3) ◽  
Author(s):  
Kazuaki Okino ◽  
Keita Yamazaki ◽  
Keiichiro Okada ◽  
Keiji Fujimoto ◽  
HIROKI ADACHI ◽  
...  
Keyword(s):  
Renal Transplantation ◽  
Renal Allograft ◽  
Patient Survival ◽  
Hcv Infection ◽  
Hcv Rna ◽  
Direct Acting Antivirals ◽  
Group A ◽  
Group B ◽  
Direct Acting ◽  
The Impact

Abstract Background and Aims The impact of hepatitis C virus (HCV) infection on patient survival after renal transplantation was worse. Previously, we found that continuous HCV infection was a significant independent risk factor for actuarial survival (especially at ≥20 years after the transplant procedure) among Japanese renal allograft recipients. This study evaluates the impact of HCV and of the new direct acting antivirals (DAAs) on patient outcomes in renal allograft recipients. Method We studied 46 cases (28 males, 18 females; 37 living-donor cases, 9 deceased-donor cases; mean follow-up period 305 months ranging from 2 to 420 months) out of the 315 renal transplanted patients who underwent the first renal transplantation in Kanazawa Medical University since 1974. They had antibodies against HCV: 11 were positive for HCV RNA and received DAAs (Group A, all of them genotype 1b); 27 were HCV RNA positive and did not receive any treatment (Group B); 8 were negative for HCV RNA (Group C) (Fig.1). Results All Group A patients had HCV RNA negativity after 2-12 weeks of treatment started, and 11 (100%) achieved a sustained virological response (SVR) at 24 weeks. All of them had no adverse effects by the use of DAAs. In this cohort, no patients in Group A died. On the other hand, 15 (55.5％) of 27 in Group B and 3 (37.5%) of 8 in Group C died. Causes of death among Group B were liver cirrhosis (5 cases), hepatocellular carcinoma (2 case), infections complicated with chronic hepatitis (6 cases) in chronic phase, fibrosing cholestatic hepatitis due to HCV (1 case) after surgery, and cardiovascular disease (1 case). The patient survival rate was significantly higher in Group A patients who received DAAs by Kaplan- Meier life table method (Log Rank test, Kay-square 11.7, p=0.004) (Fig.2). Conclusion Our results support the notion that continuous HCV infection was a harmful and that new DAAs were efficient and safe to treat HCV infection after renal transplantation.

Renal Transplantation for Chronic Renal Failure in Methylmalonic Academia: A Case Report

2012 ◽  
Vol 94 (10S) ◽  
pp. 859 ◽  
Author(s):  
I. Matsumoto ◽  
T. Kenmochi ◽  
M. Maruyama ◽  
N. Akutsu ◽  
K. Ohtsuki ◽  
...  
Keyword(s):  
Renal Failure ◽  
Case Report ◽  
Renal Transplantation ◽  
Chronic Renal Failure

Hypergonadotropism in Peripubertal Boys with Chronic Renal Failure

PEDIATRICS ◽  
1983 ◽  
Vol 72 (3) ◽  
pp. 384-389
Author(s):  
Harold K. Marder ◽  
Laxmi S. Srivastava ◽  
Stephen Burstein
Keyword(s):  
Renal Failure ◽  
Chronic Renal Failure ◽  
Elevated Serum ◽  
Serum Testosterone ◽  
Normal Serum ◽  
Adult Men ◽  
Testicular Dysfunction ◽  
Serum Luteinizing Hormone ◽  
Serum Lh ◽  
Serum Gonadotropin

Serum gonadotropin and testosterone concentrations were measured in ten peripubertal boys to assess the effects of uremia on pubertal maturation. Serum luteinizing hormone (LH) concentrations were elevated for stage of puberty in eight boys, whereas in most boys serum follicle-stimulating hormone and testosterone concentrations were normal. Serum LH concentrations correlated with the severity of uremia. LH levels declined when measured 1 year after the initial measurements in four boys who received renal allografts, but were further elevated in two boys who were treated conservatively. Elevated serum LH concentrations in the presence of normal serum testosterone concentrations imply limited testicular sensitivity to the effects of LH in these peripubertal boys, as has been documented for adult men with chronic renal failure. Alternatively, there may be accumulation of an immunoreactive LH molecule that lacks bioactivity. A testicular dysfunction may explain the pubertal delay experienced by some uremic adolescent boys.

Continuous Ambulatory Peritoneal Dialysis in South Africa -A Four-Year Experience

1984 ◽  
Vol 4 (2) ◽  
pp. 78-81 ◽  
Author(s):  
I. Parsoo ◽  
Y.K. Seedat ◽  
S. Naicker ◽  
J.C. Kallmeyer
Keyword(s):  
South Africa ◽  
Developing Countries ◽  
Renal Failure ◽  
Peritoneal Dialysis ◽  
Renal Transplantation ◽  
Chronic Renal Failure ◽  
Continuous Ambulatory Peritoneal Dialysis ◽  
Minority Groups ◽  
Alternative Therapy ◽  
Major Complication

This study describes our experience with continuous ambulatory peritoneal dialysis (CAPD) over a four year period, during which 88 patients were offered CAPD. It compares and contrasts the response to CAPD among four racial groups in Natal viz asiatics, blacks, coloureds and whites. Peritonitis -the major complication, occurred with an overall incidence of one episode every 4.41 patient months. CAPD remains a useful alternative therapy in developing countries where a high percentage of patients with chronic renal failure would be denied a chronic renal failure program because of lack of expertise in hemodialysis and/or renal transplantation, or limited financial resources. Continuous ambulatory peritoneal dialysis (CAPD) was first described by Moncrief and Popovich (1) and, since its modification by Oreopoulos and his group (2), this technique has gained world wide usage. South Africa, like many developing countries has a high incidence of end-stage renal disease (ESRD) but because of lack of resources and economical problems, few patients with ESRD can be treated by dialysis or renal transplantation. CAPD affords a relatively simple and inexpensive form of therapy for these patients. At the present time about 200 patients are on CAPD in South Africa. Natal, the smallest of four provinces in South Africa, has a population of about five million, the majority being blacks. The minority groups include whites, asiatics and coloureds. There is only one chronic dialysis centre in Natal; situated in Durban, it serves the entire province including parts of the Transkei. This paper describes a four-year experience with CAPD in this mixed population and discusses problems unique to this situation.

Sign in / Sign up

Export Citation Format

Share Document